D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 87 Citations 30,129 436 World Ranking 7093 National Ranking 299

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Laurence Klotz focuses on Prostate cancer, Internal medicine, Surgery, Prostate and Cancer. Her Prostate cancer research is multidisciplinary, incorporating perspectives in Biopsy, Radiology and Gynecology. Her research integrates issues of Endocrinology and Oncology in her study of Internal medicine.

Laurence Klotz combines subjects such as Nephrectomy, Kidney disease and Urology with her study of Surgery. Her Prostate research is multidisciplinary, relying on both Hormonal therapy and General surgery. In the subject of general Cancer, her work in PCA3 is often linked to Erg, Fusion gene and TMPRSS2, thereby combining diverse domains of study.

Her most cited work include:

  • Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) (1103 citations)
  • Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer (897 citations)
  • MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (876 citations)

What are the main themes of her work throughout her whole career to date?

The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Oncology, Cancer and Surgery. Her Prostate cancer research integrates issues from Prostate, Disease and Urology. Her Prostate research focuses on Biopsy and how it relates to Prostate biopsy.

Her work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Gynecology. Her studies in Oncology integrate themes in fields like Stage, Androgen, Bicalutamide and PCA3. Surgery connects with themes related to Cohort in her study.

She most often published in these fields:

  • Prostate cancer (68.38%)
  • Internal medicine (54.98%)
  • Oncology (39.56%)

What were the highlights of her more recent work (between 2017-2021)?

  • Prostate cancer (68.38%)
  • Internal medicine (54.98%)
  • Oncology (39.56%)

In recent papers she was focusing on the following fields of study:

Laurence Klotz mostly deals with Prostate cancer, Internal medicine, Oncology, Cancer and Radiology. The various areas that Laurence Klotz examines in her Prostate cancer study include Magnetic resonance imaging, Biopsy, Prostate and Disease. Her work in Biopsy addresses issues such as Prostate-specific antigen, which are connected to fields such as Risk assessment and Cohort study.

Within one scientific family, she focuses on topics pertaining to Urology under Prostate, and may sometimes address concerns connected to Prospective cohort study and International Prostate Symptom Score. Laurence Klotz has included themes like Apalutamide, Adverse effect, Enzalutamide, Androgen and Hazard ratio in her Oncology study. Her Cancer study combines topics in areas such as Nephrology and Retrospective cohort study.

Between 2017 and 2021, her most popular works were:

  • MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (876 citations)
  • Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial (63 citations)
  • Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations (60 citations)

In her most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Disease

Laurence Klotz focuses on Prostate cancer, Internal medicine, Cancer, Biopsy and Oncology. Her work deals with themes such as Magnetic resonance imaging, Radiology and Disease, which intersect with Prostate cancer. Her Internal medicine study incorporates themes from Action plan and Distress.

Her biological study spans a wide range of topics, including Randomized controlled trial and Retrospective cohort study. Her Biopsy research incorporates elements of T-stage, Tumour stage, Repeat biopsy, Prostate biopsy and Receiver operating characteristic. Her Oncology study combines topics from a wide range of disciplines, such as Androgen, Enzalutamide and Cohort.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley.
JAMA (2011)

1710 Citations

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Veeru Kasivisvanathan;Antti S. Rannikko;Marcelo Borghi;Valeria Panebianco.
The New England Journal of Medicine (2018)

1293 Citations

Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer

Laurence Klotz;Liying Zhang;Adam Lam;Robert Nam.
Journal of Clinical Oncology (2010)

1263 Citations

Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer

Laurence Klotz;Laurence Klotz;Danny Vesprini;Danny Vesprini;Perakaa Sethukavalan;Perakaa Sethukavalan;Vibhuti Jethava;Vibhuti Jethava.
Journal of Clinical Oncology (2015)

975 Citations

A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

Hendrik Van Poppel;Luigi Da Pozzo;Walter Albrecht;Vsevolod Matveev.
European Urology (2007)

828 Citations

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.

Robert K. Nam;Robert K. Nam;Refik Saskin;Yuna Lee;Ying Liu.
The Journal of Urology (2010)

674 Citations

Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

Marc A. Dall’Era;Peter C. Albertsen;Christopher Bangma;Peter R. Carroll.
European Urology (2012)

624 Citations

Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review.

Caroline M. Moore;Caroline M. Moore;Nicola L. Robertson;Nasr Arsanious;Thomas Middleton.
European Urology (2013)

586 Citations

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

J. M Crook;C. J O'Callaghan;G Duncan;D. P Dearnaley.
The New England Journal of Medicine (2012)

455 Citations

Loss of Cyclin-dependent Kinase Inhibitor p27Kip1 Is a Novel Prognostic Factor in Localized Human Prostate Adenocarcinoma

Tsihlias J;Kapusta Lr;DeBoer G;Morava-Protzner I.
Cancer Research (1998)

453 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Laurence Klotz

Mark Emberton

Mark Emberton

University College London

Publications: 203

Hashim U. Ahmed

Hashim U. Ahmed

Imperial College Healthcare NHS Trust

Publications: 172

Peter R. Carroll

Peter R. Carroll

University of California, San Francisco

Publications: 134

Monique J. Roobol

Monique J. Roobol

Erasmus MC

Publications: 109

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 108

Matthew R. Cooperberg

Matthew R. Cooperberg

University of California, San Francisco

Publications: 95

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 95

Baris Turkbey

Baris Turkbey

National Institutes of Health

Publications: 88

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 88

Eric A. Klein

Eric A. Klein

Cleveland Clinic

Publications: 87

Ian M. Thompson

Ian M. Thompson

The University of Texas Health Science Center at San Antonio

Publications: 84

Peter T. Scardino

Peter T. Scardino

Memorial Sloan Kettering Cancer Center

Publications: 82

Neil Fleshner

Neil Fleshner

Princess Margaret Cancer Centre

Publications: 80

H. Ballentine Carter

H. Ballentine Carter

Johns Hopkins University School of Medicine

Publications: 77

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 76

Jonathan I. Epstein

Jonathan I. Epstein

Johns Hopkins University

Publications: 76

Trending Scientists

Eddy Y. Zeng

Eddy Y. Zeng

Jinan University

Rajni Hatti-Kaul

Rajni Hatti-Kaul

Lund University

Sherri J. Bale

Sherri J. Bale

OPKO Health (United States)

Olli Peltoniemi

Olli Peltoniemi

University of Helsinki

Munusamy Madhaiyan

Munusamy Madhaiyan

National University of Singapore

Thomas M. McIntyre

Thomas M. McIntyre

University of Utah

Fusao Hirata

Fusao Hirata

Johns Hopkins University

Quansheng Ge

Quansheng Ge

Chinese Academy of Sciences

Samuel M. Behar

Samuel M. Behar

University of Massachusetts Medical School

Steffen Moritz

Steffen Moritz

Universität Hamburg

Jan M. Lundberg

Jan M. Lundberg

Karolinska Institute

David M. Nagorney

David M. Nagorney

Mayo Clinic

Ronenn Roubenoff

Ronenn Roubenoff

Novartis (Switzerland)

John F. Seymour

John F. Seymour

Peter MacCallum Cancer Centre

Alan Frazer

Alan Frazer

The University of Texas Health Science Center at San Antonio

Something went wrong. Please try again later.